Multiple outlets report that Victorian taxpayers are funding the provision of weight-loss medications for prisoners, including Ozempic (semaglutide). The coverage describes a scheme under which inmates are supplied with such drugs as part of their access to health services while in custody. All three articles present the same core claim: that public funding in Victoria covers the costs associated with prisoners using these medications. The reports indicate the issue has attracted attention because these drugs are generally associated with weight management and may be costly, making the use of public money for prisoners’ access a matter of public interest.
While the articles share the central message about taxpayer-funded access to Ozempic in prison, they do not provide significant differing details in the information supplied here. Taken together, the reports focus on who pays for the medications and that the medications include Ozempic, framing the situation as a government-funded health expenditure for people in custody.
